Activism unleashed and unconscionable

Article Abstract:

Activists' arguments which benefit society most of the time can run counter to society's interests when they become relentlessly antagonistic to a corporate sector like the drug industry that has improved the public's health and well-being for decades. However, it is argued that it is essential for drug companies to own their inventions and data to enable innovators to support sales, marketing and post-marketing surveillance activities, hence the compulsory transfer of proprietary inventions, technologies and data into the public domain constitutes a seizure of assets.

Pharmaceutical preparations, Pharmaceutical industry, Technology application, Political issue, Activism

---

FDA on transgenic animals-a dog's breakfast?

Article Abstract:

The author feels that U.S. Food and Drug Administration (FDA) should consider a definite and scientific policy on transgenic animals and offer more thoughtful and scientific products for transgenic animals as the drafts from the FDA's Center for Veterinary Medicine (CVM) about the regulation of transgenic animals reflect an illogical and torturous policy.

Legal issues & crime, Government regulation (cont), Government regulation, Legal/Government Regulation, Laws, regulations and rules, Genetically modified animals, United States. Food and Drug Administration

---

Will we reap what biopharming sows?

Article Abstract:

The safety of the biopharming process in transgenic crop development is discussed.

Product development, General services, Agricultural industry, Safety and security measures, Economic aspects, Biotechnology industry, Biotechnology industries, Column, Genetically modified plants, Pharmaceutical biotechnology

Similar abstracts:

• Abstracts: Pride and professionalism. Back on the front foot. With the public interest at heart
• Abstracts: Interaction of the Final Regs. on partnership technical terminations with TRA '97. Final disguised sales regs. add clarification but leave some issues unaddressed
• Abstracts: Long- and short-run non-parametric cost frontier efficiency: an application to Spanish savings banks. Endogenous product differentiation in credit markets: what do borrowers pay for?
• Abstracts: Critics pan timid European response to TeGenero disaster. Europe's anti-GM stance to presage animal feed shortage?

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.